Wedbush Securities’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $369K | Buy |
|
|||||
|
2025
Q1 | $327K | Sell |
|
|||||
|
2024
Q4 | $469K | Buy |
|
|||||
|
2024
Q3 | $380K | Sell |
|
|||||
|
2024
Q2 | $462K | Sell |
|
|||||
|
2024
Q1 | $449K | Buy |
|
|||||
|
2023
Q4 | $290K | Sell |
|
|||||
|
2023
Q3 | $291K | Sell |
|
|||||
|
2023
Q2 | $253K | Sell |
|
|||||
|
2023
Q1 | $309K | Sell |
|
|||||
|
2022
Q4 | $326K | Sell |
|
|||||
|
2022
Q3 | $331K | Buy |
|
|||||
|
2022
Q2 | $286K | Sell |
|
|||||
|
2022
Q1 | $359K | Sell |
|
|||||
|
2021
Q4 | $308K | Sell |
|
|||||
|
2021
Q3 | $378K | Sell |
|
|||||
|
2021
Q2 | $402K | Sell |
|
|||||
|
2021
Q1 | $471K | Buy |
|
|||||
|
2020
Q4 | $300K | Sell |
|
|||||
|
2020
Q3 | $313K | Sell |
|
|||||
|
2020
Q2 | $460K | Sell |
|
|||||
|
2020
Q1 | $464K | Buy |
|
|||||
|
2019
Q4 | $486K | Buy |
|
|||||
|
2019
Q3 | $291K | Buy |
|
|||||
|
2019
Q2 | $295K | Buy |
|
|||||
|
2019
Q1 | $445K | Buy |
|
|||||
|
2018
Q4 | $422K | Sell |
|
|||||
|
2018
Q3 | $668K | Sell |
|
|||||
|
2018
Q2 | $791K | Sell |
|
|||||
|
2018
Q1 | $829K | Sell |
|
|||||
|
2017
Q4 | $1.51M | Sell |
|
|||||
|
2017
Q3 | $1.71M | Buy |
|
|||||
|
2017
Q2 | $2.4M | Buy |
|
|||||
|
2017
Q1 | $1.77M | Buy |
|
|||||
|
2016
Q4 | $963K | Buy |
|
|||||
|
2016
Q3 | $347K | Buy |
|
|||||
|
2016
Q2 | $279K | Buy |
|
|||||
|
2016
Q1 | $280K | Buy |
|
|||||
|
2015
Q4 | $283K | Sell |
|
|||||
|
2015
Q3 | $254K | Buy |
|
|||||
|
2015
Q2 | $208K | Sell |
|
|||||
|
2015
Q1 | $245K | Sell |
|
|||||
|
2014
Q4 | $276K | Sell |
|
|||||
|
2014
Q3 | $342K | Sell |
|
|||||
|
2014
Q2 | $738K | Sell |
|
|||||
|
2014
Q1 | $745K | Sell |
|
|||||
|
2013
Q4 | $727K | Sell |
|
|||||
|
2013
Q3 | $698K | Sell |
|
|||||
|
2013
Q2 | $726K | Buy |
|